Gastric cancer organoids: a promising model for personalized treatment of gastric cancer
Authors:
Open Access
- 29 January 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1712621
Abstract
Gastric cancer is one of the most prevalent malignant tumors in the gastrointestinal tract. At present, the main treatment methods of gastric cancer include chemotherapy, targeted therapy and immunotherapy. However, due to the strong heterogeneity of tumor cells, the current treatment schemes have different effects on each patient. Therefore, individualized treatment strategies for different patients have become an inevitable trend. The organoid model is an emerging technology for three-dimensional (3D) cell culture in vitro , which can simulate the three-dimensional structure of real organs and the interaction between cells, while retaining the heterogeneity of patients’ tumor cells. The response of organoid model to treatment can replace the response of patients’ tumor cells to treatment. Organoid model of gastric cancer can effectively bridge the basic research and clinical practice, and show remarkable transformation potential and broad application prospects in promoting individualized treatment of gastric cancer. In this paper, the establishment methods of organoid model of gastric cancer are systematically reviewed, and its application in drug sensitivity detection, biomarker discovery and mechanism research is discussed, in order to provide theoretical basis and practical reference for the development of precise treatment strategy for gastric cancer.Keywords
This publication has 110 references indexed in Scilit:
- Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1Advanced Science, 2023
- American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidenceGastrointestinal Endoscopy, 2023
- Early stage gastric adenocarcinoma: clinical and molecular landscapesNature Reviews Clinical Oncology, 2023
- VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancerEBioMedicine, 2023
- Multidisciplinary treatment strategy for locally advanced gastric cancer: A systematic reviewSurgical Oncology, 2021
- Reconstructing the tumor architecture into organoidsAdvanced Drug Delivery Reviews, 2021
- Generation and use of gastric organoids for the study of Helicobacter pylori pathogenesis2020
- Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screeningJournal of Cancer Research and Clinical Oncology, 2019
- Gastric Organoids: An Emerging Model System to Study Helicobacter pylori Pathogenesis2017
- Organoid Culture of Human Cancer Stem Cells2016